{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T19:05:00Z","timestamp":1781723100431,"version":"3.54.5"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.antiviral.2020.104789","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T15:15:32Z","timestamp":1588000532000},"page":"104789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["LINCS dataset-based repositioning of rosiglitazone as a potential anti-human adenovirus drug"],"prefix":"10.1016","volume":"179","author":[{"given":"Xiaolong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenguo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104789_bib1","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1099\/0022-1317-81-11-2605","article-title":"Blood clearance rates of adenovirus type 5 in mice","volume":"81","author":"Alemany","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2020.104789_bib2","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1169920","article-title":"Drug discovery. Repurposing with a difference","volume":"324","author":"Boguski","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2020.104789_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/13550289909029746","article-title":"Differential chemokine induction by the mouse adenovirus type-1 in the central nervous system of susceptible and resistant strains of mice","volume":"5","author":"Charles","year":"1999","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.antiviral.2020.104789_bib4","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1189\/jlb.71.3.388","article-title":"The role of PPARs in inflammation and immunity","volume":"71","author":"Clark","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.antiviral.2020.104789_bib5","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nri912","article-title":"Emerging roles of PPARs in inflammation and immunity","volume":"2","author":"Daynes","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2020.104789_bib6","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/s41598-018-37249-4","article-title":"Molecular evolution of human adenovirus (HAdV) species C","volume":"9","author":"Dhingra","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2020.104789_bib7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12985-017-0765-x","article-title":"Peroxisome proliferators activated receptor (PPAR) agonists activate hepatitis B virus replication in vivo","volume":"14","author":"Du","year":"2017","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2020.104789_bib8","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/CMR.00052-07","article-title":"Adenoviruses in immunocompromised hosts","volume":"21","author":"Echavarria","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2020.104789_bib9","doi-asserted-by":"crossref","first-page":"758","DOI":"10.12688\/f1000research.8374.2","article-title":"Use of cidofovir in pediatric patients with adenovirus infection","volume":"5","author":"Ganapathi","year":"2016","journal-title":"F1000 Res."},{"key":"10.1016\/j.antiviral.2020.104789_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1556\/EuJMI.4.2014.1.2","article-title":"Human adenovirus: viral pathogen with increasing importance","volume":"4","author":"Ghebremedhin","year":"2014","journal-title":"Eur. J. Microbiol. Immun."},{"key":"10.1016\/j.antiviral.2020.104789_bib11","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.biopha.2018.11.127","article-title":"An update on drug repurposing: re-written saga of the drug's fate","volume":"110","author":"Gns","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.antiviral.2020.104789_bib12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3390\/v11060505","article-title":"Peroxisome proliferator-activated receptor gamma (PPAR\u03b3) suppresses inflammation and bacterial clearance during influenza-bacterial super-infection","volume":"11","author":"Gopal","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2020.104789_bib13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00003226-199211000-00008","article-title":"Pretreatment with topical 0.1% (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine inhibits adenovirus type 5 replication in the New Zealand rabbit ocular model","volume":"11","author":"Gordon","year":"1992","journal-title":"Cornea"},{"key":"10.1016\/j.antiviral.2020.104789_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2012.06.011","article-title":"Inhibition of rotavirus infection in cultured cells by N-acetyl-cysteine, PPAR gamma agonists and NSAIDs","volume":"96","author":"Guererero","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104789_bib15","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1590\/0074-0276108062013011","article-title":"Inhibition of rotavirus ECwt infection in ICR suckling mice by N-acetylcysteine, peroxisome proliferator-activated receptor gamma agonists and cyclooxygenase-2 inhibitors","volume":"108","author":"Guerrero","year":"2013","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.antiviral.2020.104789_bib16","doi-asserted-by":"crossref","first-page":"14969","DOI":"10.1038\/s41598-018-33039-0","article-title":"LINCS L1000 dataset-based repositioning of CGP-60474 as a highly potent anti-endotoxemic agent","volume":"8","author":"Han","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2020.104789_bib17","article-title":"Adenovirus DNA replication","volume":"5","author":"Hoeben","year":"2013","journal-title":"CSH Perspect. Biol."},{"key":"10.1016\/j.antiviral.2020.104789_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jep.2009.02.028","article-title":"The cytotoxicity to leukemia cells and antiviral effects of Isatis indigotica extracts on pseudorabies virus","volume":"123","author":"Hsuan","year":"2009","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.antiviral.2020.104789_bib19","first-page":"193817","article-title":"Drug repositioning discovery for early- and late-stage non-small-cell lung cancer","author":"Huang","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.antiviral.2020.104789_bib20","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1128\/JVI.80.7.3549-3558.2006","article-title":"Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species","volume":"80","author":"Jogler","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104789_bib21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/jmv.10475","article-title":"Acute inflammatory response and remodeling of airway epithelium after subspecies B1 human adenovirus infection of the mouse lower respiratory tract","volume":"71","author":"Kajon","year":"2003","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2020.104789_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2003.08.003","article-title":"The cotton rat model for adenovirus ocular infection: antiviral activity of cidofovir","volume":"61","author":"Kaneko","year":"2004","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104789_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nbt.3367","article-title":"Mapping the effects of drugs on the immune system","volume":"34","author":"Kidd","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.antiviral.2020.104789_bib24","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.cmet.2011.03.020","article-title":"mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass","volume":"13","author":"Kunkel","year":"2011","journal-title":"Cell Metabol."},{"key":"10.1016\/j.antiviral.2020.104789_bib25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nrc2044","article-title":"The Connectivity Map: a new tool for biomedical research","volume":"7","author":"Lamb","year":"2007","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.antiviral.2020.104789_bib26","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1128\/AAC.49.11.4689-4699.2005","article-title":"Mouse adenovirus type 1 infection in SCID mice: an experimental model for antiviral therapy of systemic adenovirus infections","volume":"49","author":"Lenaerts","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104789_bib27","doi-asserted-by":"crossref","first-page":"8798","DOI":"10.1128\/jvi.71.11.8798-8807.1997","article-title":"The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors","volume":"71","author":"Lieber","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104789_bib28","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.cell.2015.05.011","article-title":"Treatment of obesity with celastrol","volume":"161","author":"Liu","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2020.104789_bib29","article-title":"Adenoviruses associated with acute diarrhea in children in Beijing, China","volume":"9","author":"Liu","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104789_bib30","first-page":"493","article-title":"Revisiting Connectivity Map from a gene co-expression network analysis","volume":"16","author":"Liu","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.antiviral.2020.104789_bib31","doi-asserted-by":"crossref","first-page":"E3725","DOI":"10.1073\/pnas.1520289113","article-title":"Connectivity mapping (ssCMap) to predict A20-inducing drugs and their antiinflammatory action in cystic fibrosis","volume":"113","author":"Malcomson","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2020.104789_bib32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0166-3542(00)00088-7","article-title":"Evaluation of the efficacy of 2',3'-dideoxycytidine against adenovirus infection in a mouse pneumonia model","volume":"47","author":"Mentel","year":"2000","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104789_bib33","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1128\/JVI.78.11.5584-5590.2004","article-title":"Fatal disseminated mouse adenovirus type 1 infection in mice lacking B cells or Bruton's tyrosine kinase","volume":"78","author":"Moore","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104789_bib34","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3389\/fgene.2019.00557","article-title":"L1000 viewer: a search engine and web interface for the lincs data repository","volume":"10","author":"Musa","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.antiviral.2020.104789_bib35","doi-asserted-by":"crossref","first-page":"7849","DOI":"10.1038\/s41598-019-44291-3","article-title":"Systems pharmacogenomic landscape of drug similarities from LINCS data: drug association networks","volume":"9","author":"Musa","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2020.104789_bib36","doi-asserted-by":"crossref","first-page":"9428","DOI":"10.1038\/s41598-019-45878-6","article-title":"Peroxisome proliferator-activated receptor-gamma agonists exhibit anti-inflammatory and antiviral effects in an EcoHIV mouse model","volume":"9","author":"Omeragic","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2020.104789_bib37","doi-asserted-by":"crossref","first-page":"14747","DOI":"10.1074\/jbc.M210819200","article-title":"15d-PGJ2 and rosilglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS1) and SOCS3 in glia","volume":"278","author":"Park","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104789_bib38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1128\/jvi.67.1.101-111.1993","article-title":"Pathogenesis of adenovirus type 5 pneumonia in cotton rats (Sigmodon hispidus)","volume":"67","author":"Prince","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104789_bib39","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s10916-019-1173-0","article-title":"Detecting secular trends in clinical treatment through temporal analysis","volume":"43","author":"Redd","year":"2019","journal-title":"J. Med. Syst."},{"key":"10.1016\/j.antiviral.2020.104789_bib40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0166-3542(01)00166-8","article-title":"Antiviral prophylaxis with twice daily topical cidofovir protects against challenge in the adenovirus type 5\/New Zealand rabbit ocular model","volume":"52","author":"Romanowski","year":"2001","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104789_bib41","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1128\/jvi.64.1.78-85.1990","article-title":"Topoisomerase I and II cleavage of adenovirus DNA in vivo: both topoisomerase activities appear to be required for adenovirus DNA replication","volume":"64","author":"Schaack","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104789_bib42","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/nar\/18.6.1499","article-title":"Transcription of adenovirus and HeLa cell genes in the presence of drugs that inhibit topoisomerase I and II function","volume":"18","author":"Schaak","year":"1990","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2020.104789_bib43","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1017\/S1047951118000379","article-title":"Successful treatment of disseminated adenovirus infection with cidofovir and intravenous immunoglobulin in an infant following heart transplant","volume":"28","author":"Serrano","year":"2018","journal-title":"Cardiol. Young"},{"key":"10.1016\/j.antiviral.2020.104789_bib44","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1186\/s12879-019-4305-8","article-title":"Comparative study of clinical and epidemiological characteristics of major pediatric adenovirus epidemics in southern Taiwan","volume":"19","author":"Shen","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104789_bib45","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/leu.2013.245","article-title":"Chemical genomic screening identifies LY294002 as a modulator of glucocorticoid resistance in MLL-rearranged infant ALL","volume":"28","author":"Spijkers-Hagelstein","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.antiviral.2020.104789_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2018.03.145","article-title":"HMGB1 mediates HAdV-7 infection-induced pulmonary inflammation in mice","volume":"501","author":"Tang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2020.104789_bib47","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1182\/blood-2007-02-062117","article-title":"Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines","volume":"110","author":"Tatsis","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2020.104789_bib48","first-page":"2740","article-title":"Studies of adenovirus-induced eye disease in the rabbit model","volume":"36","author":"Trousdale","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.antiviral.2020.104789_bib49","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1128\/JVI.79.2.1308-1311.2005","article-title":"Productive replication of human adenovirus type 5 in canine cells","volume":"79","author":"Ternovoi","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104789_bib50","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00284-17","article-title":"Pathology in permissive Syrian hamsters after infection with species C human adenovirus (HAdV-C) is the result of virus replication: HAdV-C6 replicates more and causes more pathology than HAdV-C5","volume":"91","author":"Tollefson","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104789_bib51","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1073\/pnas.0800200105","article-title":"Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model","volume":"105","author":"Toth","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104789_bib52","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.antiviral.2017.08.002","article-title":"Combination therapy with brincidofovir and valganciclovir against species C adenovirus infection in the immunosuppressed Syrian hamster model allows for substantial reduction of dose for both compounds","volume":"146","author":"Toth","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104789_bib53","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.gt.3301845","article-title":"Genetic manipulations of adenovirus type 5 fiber resulting in liver tropism attenuation","volume":"10","author":"Vigne","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.antiviral.2020.104789_bib54","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/jpids\/pix011","article-title":"Renal toxicity in pediatric patients receiving cidofovir for the treatment of adenovirus infection","volume":"6","author":"Vora","year":"2017","journal-title":"J. Pediatric Infect. Dis. Soc."},{"key":"10.1016\/j.antiviral.2020.104789_bib55","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1016\/j.vaccine.2015.08.056","article-title":"Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats","volume":"33","author":"Widjojoatmodjo","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2020.104789_bib56","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1128\/jvi.71.1.624-629.1997","article-title":"Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ","volume":"71","author":"Wolff","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104789_bib57","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1128\/jvi.64.2.691-699.1990","article-title":"Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome","volume":"64","author":"Wong","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104789_bib58","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.antiviral.2018.01.014","article-title":"Retinoic acid receptor beta, a potential therapeutic target in the inhibition of adenovirus replication","volume":"152","author":"Wang","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104789_bib59","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1186\/s12864-018-5031-0","article-title":"Deep learning-based transcriptome data classification for drug-target interaction prediction","volume":"19","author":"Xie","year":"2018","journal-title":"BMC Genom."},{"key":"10.1016\/j.antiviral.2020.104789_bib60","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/jmv.25333","article-title":"Epidemiology of human adenovirus infection in children hospitalized with lower respiratory tract infections in Hunan, China","volume":"91","author":"Xie","year":"2019","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2020.104789_bib61","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fmicb.2019.00130","article-title":"Transcriptome sequencing identifies novel immune response genes highly related to the severity of human adenovirus type 55 infection","volume":"10","author":"Xu","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.antiviral.2020.104789_bib62","doi-asserted-by":"crossref","first-page":"9781a","DOI":"10.1038\/s41598-019-46228-2","article-title":"Human adenovirus species C recombinant virus continuously circulated in China","volume":"9","author":"Yang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2020.104789_bib63","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.virol.2017.10.015","article-title":"Male Syrian hamsters are more susceptible to intravenous infection with species C human adenoviruses than are females","volume":"514","author":"Ying","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104789_bib64","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jmii.2018.08.010","article-title":"Adenovirus replication and host innate response in primary human airway epithelial cells","volume":"52","author":"Yang","year":"2019","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.antiviral.2020.104789_bib65","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12985-019-1185-x","article-title":"Human adenovirus among hospitalized children with respiratory tract infections in Beijing, China, 2017\u20132018","volume":"16","author":"Yao","year":"2019","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2020.104789_bib66","first-page":"215","article-title":"Adenovirus pneumonia treated with Cidofovir in an immunocompetent high school senior","volume":"26","author":"Yoon","year":"2019","journal-title":"Respir. Med. Case Rep."},{"key":"10.1016\/j.antiviral.2020.104789_bib67","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.gene.2018.09.040","article-title":"Weighted gene co-expression network analysis and connectivity map identifies lovastatin as a treatment option of gastric cancer by inhibiting HDAC2","volume":"681","author":"Zhang","year":"2019","journal-title":"Gene"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220302035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220302035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:32:04Z","timestamp":1759062724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354220302035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":67,"alternative-id":["S0166354220302035"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104789","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LINCS dataset-based repositioning of rosiglitazone as a potential anti-human adenovirus drug","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104789","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104789"}}